Search

Search Constraints

You searched for: Author/Creator Niccoli, Patricia

Search Results

1. Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial. Issue 3 (March 2023)

2. Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Issue 17 (23rd June 2022)

3. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations. (December 2018)

4. Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR. (November 2021)

5. Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?. (25th January 2013)

8. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ⩽2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines. Issue 1 (July 2018)

9. Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial. Issue 12 (20th August 2022)

10. Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne). Issue 6 (December 2020)